Complement Therapeutics
@ComplementTx
Developing the next generation of complement medicines
내가 좋아할 만한 콘텐츠
𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: @ComplementTx received IND clearance from U.S. FDA today to start a trial of its AAV gene therapy for geographic atrophy that delivers a truncated version of Complement Receptor 1 to the eye. Full video: biotechtv.com/post/complemen…
We welcome Kate to the team as our Vice President, Regulatory Affairs. 🎉 #WelcomeAboard #GeneTherapy #ophthalmology #ComplementBiology #team #JobOpening #JoinUs
Very pleased to present this online Tutorial around the role of the Complement System in Disease in conjunction with the Stephen J Ryan Initiative for Macular Research (RIMR) and the Doheny Eye Institute youtu.be/AEkKDDYMcyk?si… via @YouTube #complement #Macula @DohenyEye
youtube.com
YouTube
2024 RIMR - Simon Clark, PhD - Complement association with disease
We welcome Jen to the team as our Vice President, Clinical Operations. 🎉 #WelcomeAboard #GeneTherapy #ophthalmology #ComplementBiology #team #JobOpening #JoinUs
Great to see @ComplementTx gaining recognition for its work on the Complement Precision Medicine (CPM) platform. Patient stratification should be a major focus for clinical success. @RDUnwin #complementbiology #complementsystem #immunology ukt.news/is-biotechs-fu…
Please join us in extending a warm welcome to our Chief Technology Officer, Dr. Matthias Hebben! 🎉 Read more about Matthias and our continued growth in the full release here: bit.ly/3TbgxDr #biotech #ophthalmology #genetherapy #complement #chieftechnologyofficer #CTO
📢The first patient enrolled in our i-GAIN Natural History Study! We will be recruiting 250 patients with geographic atrophy (#GA) secondary to age-related macular degeneration (#AMD) across the UK and US over the next 12 months. Find out more here: bit.ly/465S2KW
We welcome Sofiya to the team as our Scientist, Pharmacology. 🎉 #WelcomeAboard #GeneTherapy #ophthalmology #ComplementBiology #team #JobOpening #JoinUs
We welcome Thanos to the team as our Director, Pharmacology. 🎉 #WelcomeAboard #GeneTherapy #ophthalmology #ComplementBiology #team #JobOpening #JoinUs
A comprehensive review by @ProfClark M. Ueffing et al discusses the role of #complementbiology in #ocular disease, provides overview of #therapeutics & raises awareness on #time of intervention, proper #delivery routes & #patient selection Worth reading! sciencedirect.com/science/articl…
We welcome Rachel to the team as our Director, Biomarker/Bioanalytical. 🎉 #WelcomeAboard #GeneTherapy #ophthalmology #ComplementBiology #team #JobOpening #JoinUs
We welcome Rachel to the team as our Senior Vice President, Development Operations. 🎉 #WelcomeAboard #GeneTherapy #ophthalmology #ComplementBiology #team #JobOpening #JoinUs
We welcome Nakul to the team as our Scientist, Analytical Development. 🎉 #WelcomeAboard #GeneTherapy #ophthalmology #ComplementBiology #team #JobOpening #JoinUs
We welcome Suhnrita to the team as our Senior Scientist, Pharmacology. 🎉 #WelcomeAboard #GeneTherapy #ophthalmology #ComplementBiology #team #JobOpening #JoinUs
Please join us in extending a warm welcome to our Chief Medical Officer, Dr. Parisa Zamiri, MD! 🎉 Read more about Parisa and our continued growth in the full release here: bit.ly/44Vp9kS #biotech #ophthalmology #genetherapy #complementbiology #chiefmedicalofficer #CMO
We welcome Patience to the team as our Business Administration Manager. 🎉 #WelcomeAboard #GeneTherapy #ophthalmology #ComplementBiology #team #JobOpening #JoinUs
United States 트렌드
- 1. Penn State 18.9K posts
- 2. #twitchrecap 12.5K posts
- 3. #TADCFriend 1,583 posts
- 4. Romero 22.4K posts
- 5. Slay 19.9K posts
- 6. Pat Kraft 2,201 posts
- 7. Paul Dano 1,163 posts
- 8. Zion 9,629 posts
- 9. #GivingTuesday 31.5K posts
- 10. Fulham 45.1K posts
- 11. Tarantino 7,641 posts
- 12. Larry 62.1K posts
- 13. Lewandowski 27.9K posts
- 14. Sabrina Carpenter 43.1K posts
- 15. Adam Thielen 4,075 posts
- 16. Alek Manoah N/A
- 17. Franklin 66.8K posts
- 18. #LightningStrikes N/A
- 19. Pedri 59.2K posts
- 20. Rashford 10.8K posts
Something went wrong.
Something went wrong.